Institutional Ownership Ovid Therapeutics Inc. (OVID)
This table provides information about the institutional ownership of Ovid Therapeutics Inc. (OVID). We have compiled data on the 82 institutions that hold shares in the stock, with a total of 40.7 Million shares, which have been reported (via 13F filing form) to have a value of $23.2 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rubric Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
5,315,969
shares
|
$3.03 Million
0.08% of portfolio
|
Q4 2023
Reduced 2.39%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,992,346
shares
|
$2.28 Million
0.0% of portfolio
|
Q2 2024
Reduced 4.84%
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,853,818
shares
|
$2.2 Million
0.13% of portfolio
|
Q1 2024
Reduced 43.75%
|
|
Madison Avenue Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,722,627
shares
|
$2.12 Million
0.55% of portfolio
|
Q4 2024
Reduced 9.57%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,148,082
shares
|
$1.79 Million
0.0% of portfolio
|
Q4 2024
Added 0.18%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,850,000
shares
|
$1.62 Million
0.12% of portfolio
|
Q3 2024
New holding
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
1,850,601
shares
|
$1.05 Million
0.01% of portfolio
|
Q4 2024
Added 0.18%
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Feb 13, 2025 Q4 2024 |
1,545,387
shares
|
$880,870
0.03% of portfolio
|
Q4 2024
Added 1.14%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
1,418,306
shares
|
$808,434
0.0% of portfolio
|
Q4 2024
Reduced 3.11%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,400,191
shares
|
$798,108
0.01% of portfolio
|
Q2 2024
New holding
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,394,518
shares
|
$794,875
0.0% of portfolio
|
Q4 2024
Added 2.43%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,329,435
shares
|
$757,777
0.0% of portfolio
|
Q4 2024
Added 0.92%
|
|
Sio Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$570,000
0.35% of portfolio
|
Q4 2024
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$570,000
0.0% of portfolio
|
Q4 2024
New holding
|
|
Ubs Oconnor LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
943,416
shares
|
$537,747
0.06% of portfolio
|
Q4 2024
Added 50.16%
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
864,822
shares
|
$492,948
1.64% of portfolio
|
Q2 2022
Added 1.4%
|
|
Wells Fargo & Company
San Francisco, CA |
Feb 12, 2025 Q4 2024 |
743,807
shares
|
$423,969
0.0% of portfolio
|
Q4 2024
Added 1.17%
|
|
Tls Advisors LLC
Miami, FL |
Feb 13, 2025 Q4 2024 |
680,967
shares
|
$388,151
1.45% of portfolio
|
Q4 2024
Reduced 11.74%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
488,171
shares
|
$278,257
0.0% of portfolio
|
Q4 2024
Added 1.65%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
291,701
shares
|
$166,269
0.0% of portfolio
|
Q4 2024
New holding
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
229,115
shares
|
$130,595
0.01% of portfolio
|
Q4 2024
Reduced 25.98%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
198,123
shares
|
$112,930
0.0% of portfolio
|
Q4 2024
Added 52.08%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
189,487
shares
|
$108,007
0.0% of portfolio
|
Q4 2024
Added 14.27%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
161,808
shares
|
$92,230
0.0% of portfolio
|
Q4 2023
Reduced 4.84%
|
|
Verition Fund Management LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
147,305
shares
|
$83,963
0.0% of portfolio
|
Q4 2024
Added 96.73%
|